Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Patricia Carr

Svp, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.5M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 9SEC JAZZJazz Pharmaceuticals plc Sell 1,2876,512 held (−17%) $182.94 $235K +19.4%
Mar 2SEC JAZZJazz Pharmaceuticals plc Sell 1,25310,352 held (−11%) $194.11 $243K +12.5%
Mar 2SEC JAZZJazz Pharmaceuticals plc Sell 1,1179,235 held (−11%) $190.91 $213K +14.4%
Dec 9SEC JAZZJazz Pharmaceuticals plc Sell 1607,012 held (−2%) $171.11 $27K +27.6%
Dec 9SEC JAZZJazz Pharmaceuticals plc Sell 4,5007,012 held (−39%) $171.20 $770K +27.6%
Nov 20SEC JAZZJazz Pharmaceuticals plc Sell 697,012 held (−1%) $181.66 $13K +20.2%
Nov 20SEC JAZZJazz Pharmaceuticals plc Sell 5,2507,012 held (−43%) $182.07 $956K +20.0%
  • Sell

    Svp, Chief Accounting Officer Patricia Carr sold $770K of JAZZ at $171.20 — cuts the stake by 39%.

  • Sell

    Svp, Chief Accounting Officer Patricia Carr sold $956K of JAZZ at $182.07 — cuts the stake by 43%.